Comorbidity: What Is It and Why Is It Important?

  • Rhonda BrownEmail author
  • Einar Thorsteinsson


Comorbidity refers to any distinct clinical entity that coexists with or occurs during the clinical course of another illness or condition. In other words, it refers to the co-occurrence of two or more distinct illnesses, disorders or conditions in a single individual. As a result of the comorbidity, some disorders tend to occur together more often than they occur alone. For example, anxiety, depressed mood and impaired sleep often co-occur, and in this instance, the co-occurrence appears to be the rule rather than the exception.


  1. 1.
    Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. Journal of Chronic Diseases. 1970;23(7):455–468. Scholar
  2. 2.
    Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry. 2005;62(6):617–627. Scholar
  3. 3.
    Richards CS, O’Hara MW, eds. The Oxford handbook of depression and comorbidity. New York, NY: Oxford University Press; 2014.Google Scholar
  4. 4.
    Eaton WW, ed. Medical and psychiatric comorbidity over the course of life. London, UK: American Psychiatric Publishing; 2007.Google Scholar
  5. 5.
    Ross CA. The trauma model: A solution to the problem of comorbidity in psychiatry. Richardson, TX: Manitou Communications; 2007.Google Scholar
  6. 6.
    Maser JD, Cloninger CR. Comorbidity of mood and anxiety disorders. Washington, DC: American Psychiatric Press; 1990.Google Scholar
  7. 7.
    Choi-Kain LW, Gunderson JG, eds. Borderline personality and mood disorders: Comorbidity and controversy. New York, NY: Springer; 2016.Google Scholar
  8. 8.
    Whisman MA, ed. Adapting cognitive therapy for depression: Managing complexity and comorbidity. London, UK: Guilford Press; 2008.Google Scholar
  9. 9.
    Virdis A. Hypertension and comorbidities. Cham, Switzerland: Springer; 2016.CrossRefGoogle Scholar
  10. 10.
    Tohen M. Comorbidity in affective disorders. New York, NY: Dekker; 1999.Google Scholar
  11. 11.
    El Miedany Y. Comorbidity in rheumatic diseases. Cham, Switzerland: Springer; 2017.CrossRefGoogle Scholar
  12. 12.
    Mula M. Chapter 16—Epilepsy and mood disorders. In: Mula M, ed. The comorbidities of epilepsy: Academic Press; 2019:299–314.Google Scholar
  13. 13.
    Sartorius N, Holt RIG, Maj M, eds. Comorbidity of mental and physical disorders. Basel, Switzerland: Karger; 2015.Google Scholar
  14. 14.
    Pearson NJ, Johnson LL, Nahin RL. Insomnia, trouble sleeping, and complementary and alternative medicine: Analysis of the 2002 National Health Interview Survey data. Archives of Internal Medicine. 2006;166(16):1775–1782. Scholar
  15. 15.
    Cappuccio FP, Taggart FM, Kandala N-B, et al. Meta-analysis of short sleep duration and obesity in children and adults. Sleep. 2008;31(5):619–626. Scholar
  16. 16.
    Vorona RD, Winn MP, Babineau TW, Eng BP, Feldman HR, Ware JC. Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index. Archives of Internal Medicine & Health. 2005;165(1):25–30. Scholar
  17. 17.
    Yeh S-SS, Brown RF. Disordered eating partly mediates the relationship between poor sleep quality and high body mass index. Eating Behaviors. 2014;15(2):291–297. Scholar
  18. 18.
    Dixon JB, Schachter LM, O’Brien PE. Sleep disturbance and obesity: Changes following surgically induced weight loss. Archives of Internal Medicine. 2001;161(1):102–106. Scholar
  19. 19.
    Borsboom D, Cramer AOJ, Schmittmann VD, Epskamp S, Waldorp LJ. The small world of psychopathology. PLOS One. 2011;6(11):e27407. Scholar
  20. 20.
    García-Olmos L, Salvador CH, Alberquilla Á, et al. Comorbidity patterns in patients with chronic diseases in general practice. PLOS One. 2012;7(2):e32141. Scholar
  21. 21.
    Britt HC, Harrison CM, Miller GC, Knox SA. Prevalence and patterns of multimorbidity in Australia. Medical Journal of Australia. 2008;189(2):72–77. Scholar
  22. 22.
    van den Akker M, Buntinx F, Roos S, Knottnerus JA. Problems in determining occurrence rates of multimorbidity. Journal of Clinical Epidemiology. 2001;54(7):675–679. Scholar
  23. 23.
    Loza E, Jover JA, Rodriguez L, Carmona L, Group ES. Multimorbidity: Prevalence, effect on quality of life and daily functioning, and variation of this effect when one condition is a rheumatic disease. Seminars in Arthritis and Rheumatism. 2009;38(4):312–319. Scholar
  24. 24.
    U. S. Department of Health & Human Services. Multiple chronic conditions—A strategic framework: Optimum health and quality of life for individuals with multiple chronic conditions. Washington, D.C., December 2010.Google Scholar
  25. 25.
    Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2015;386(9995):743–800. Scholar
  26. 26.
    Carmona M, García-Olmos LM, Alberquilla A, et al. Heart failure in the family practice: A study of the prevalence and co-morbidity. Family Practice. 2010;28(2):128–133. Scholar
  27. 27.
    Starfield B, Lemke KW, Bernhardt T, Foldes SS, Forrest CB, Weiner JP. Comorbidity: Implications for the importance of primary care in ‘case’ management. The Annals of Family Medicine. 2003;1(1):8–14. Scholar
  28. 28.
    Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and y: Findings from the Global Burden of Disease Study 2010. PLOS Medicine. 2013;10(11):e1001547. Scholar
  29. 29.
    Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010. The Lancet. 2013;382(9904):1575–1586. Scholar
  30. 30.
    Naylor C, Parsonage M, McDaid D, Knapp M, Fossey M, Galea A. Long-term conditions and mental health: The cost of co-morbidities. London, UK: The King’s Fund; 2012.Google Scholar
  31. 31.
    Australian Bureau of Statistics. Disability, ageing and carers, Australia: Summary of findings, 2012. Canberra, Australia: Author; 2013. 4430.0.Google Scholar
  32. 32.
    White CA. Cognitive behavioral principles in managing chronic disease. Western Journal of Medicine. 2001;175(5):338–342.CrossRefGoogle Scholar
  33. 33.
    Brown RF, Valpiani EM, Tennant CC, et al. Longitudinal assessment of anxiety, depression and fatigue in people with multiple sclerosis. Psychology & Psychotherapy: Theory, Research & Practice. 2009;82:41–56. Scholar
  34. 34.
    Jansson-Fröjmark M, Lindblom K. A bidirectional relationship between anxiety and depression, and insomnia? A prospective study in the general population. Journal of Psychosomatic Research. 2008;64(4):443–449. Scholar
  35. 35.
    Valpiani EM, Brown RF, Thorsteinsson EB, Hine DW. Poor sleep quality mediates between depression to fatigue in a university student sample. Psychology and Education. 2011;48(1&2):59–71.Google Scholar
  36. 36.
    Sartorious N. Comorbidity of mental and physical diseases: A main challenge for medicine of the 21st century. Shanghai Archives of Psychiatry. 2013;25(2):68–69. Scholar
  37. 37.
    Cuijpers P, Berking M, Andersson G, Quigley L, Kleiboer A, Dobson KS. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. The Canadian Journal of Psychiatry. 2013;58(7):376–385. Scholar
  38. 38.
    Malouff JM, Thorsteinsson EB, Rooke SE, Bhullar N, Schutte NS. Efficacy of cognitive behavioral therapy for chronic fatigue syndrome: A meta-analysis. Clinical Psychology Review. 2008;28(5):736–745. Scholar
  39. 39.
    Okajima I, Komada Y, Inoue Y. A meta‐analysis on the treatment effectiveness of cognitive behavioral therapy for primary insomnia. Sleep and Biological Rhythms. 2011;9(1):24–34. Scholar
  40. 40.
    Linardon J, Wade TD, de la Piedad Garcia X, Brennan L. The efficacy of cognitive-behavioral therapy for eating disorders: A systematic review and meta-analysis. Journal of Consulting and Clinical Psychology. 2017;85(11):1080–1094. Scholar
  41. 41.
    Buscemi N, Vandermeer B, Friesen C, et al. The efficacy and safety of drug treatments for chronic insomnia in adults: A meta-analysis of RCTs. Journal of General Internal Medicine. 2007;22(9):1335. Scholar
  42. 42.
    Zammit GK. Antidepressants and insomnia. Primary Psychiatry. 2008;15(5):61–69.Google Scholar
  43. 43.
    Everitt H, Baldwin DS, Stuart B, et al. Antidepressants for insomnia in adults. Cochrane Database of Systematic Reviews. 2018(5).
  44. 44.
    McDaid D, Park A-L. Counting all the costs: The economic impact of comorbidity. In: Sartorius N, Holt RIG, Maj M, eds. Comorbidity of mental and physical disorders. Key issues mental health. Vol. 179. Basel, Switzerland: Karger; 2015:23–32.Google Scholar
  45. 45.
    Cortaredona S, Ventelou B. The extra cost of comorbidity: Multiple illnesses and the economic burden of non-communicable diseases. BMC Medicine. 2017;15(1):216. Scholar
  46. 46.
    The Royal Australian & New Zealand College of Psychiatrists. The economic cost of serious mental illness and comorbidities in Australia and New Zealand. Melbourne, Australia: Royal Australian and New Zealand College of Psychiatrists (RANZCP); 2016.Google Scholar
  47. 47.
    Vigo D, Thornicroft G, Atun R. Estimating the true global burden of mental illness. The Lancet Psychiatry. 2016;3(2):171–178. Scholar
  48. 48.
    Sayers SL, Hanrahan N, Kutney A, Clarke SP, Reis BF, Riegel B. Psychiatric comorbidity and greater hospitalization risk, longer length of stay, and higher hospitalization costs in older adults with heart failure. Journal of the American Geriatrics Society. 2007;55(10):1585–1591. Scholar
  49. 49.
    Hillman DR, Lack LC. Public health implications of sleep loss: The community burden. MJA. 2013;199(8):S7–S10. Scholar
  50. 50.
    Rosekind MR, Gregory KB, Mallis MM, Brandt SL, Seal B, Lerner D. The cost of poor sleep: Workplace productivity loss and associated costs. Journal of Occupational and Environmental Medicine. 2010;52(1):91–98. Scholar
  51. 51.
    Deloitte Access Economics. Re-awakening Australia. The economic cost of sleep disorders in Australia, 2010. Sleep Health Foundation; October 2011.Google Scholar
  52. 52.
    Zochil ML, Thorsteinsson EB. Exploring poor sleep, mental health, and help-seeking intention in university students. Australian Journal of Psychology. 2018;70(1):41–47. Scholar
  53. 53.
    Morales-Espinoza EM, Kostov B, Salami DC, et al. Complexity, comorbidity, and health care costs associated with chronic widespread pain in primary care. Pain. 2016;157(4):818–826. Scholar
  54. 54.
    Hippisley-Cox J, Fielding K, Pringle M. Depression as a risk factor for ischaemic heart disease in men: Population based case-control study. BMJ. 1998;316(7146):1714–1719. Scholar
  55. 55.
    Pi-Sunyer X. The medical risks of obesity. Postgraduate Medicine. 2009;121(6):21–33. Scholar
  56. 56.
    Katon WJ, Rutter C, Simon G, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005;28(11):2668–2672. Scholar
  57. 57.
    Lin EH, Heckbert SR, Rutter CM, et al. Depression and increased mortality in diabetes: Unexpected causes of death. The Annals of Family Medicine. 2009;7(5):414–421. Scholar
  58. 58.
    Gallicchio L, Kalesan B. Sleep duration and mortality: A systematic review and meta-analysis. Journal of Sleep Research. 2009;18(2):148–158. Scholar
  59. 59.
    Wang X, Ouyang Y, Wang Z, Zhao G, Liu L, Bi Y. Obstructive sleep apnea and risk of cardiovascular disease and all-cause mortality: A meta-analysis of prospective cohort studies. International Journal of Cardiology. 2013;169(3):207–214. Scholar
  60. 60.
    Fonseca MI, Pereira T, Caseiro P. Death and disability in patients with sleep apnea—A meta-analysis. Brazilian Archives of Cardiology. 2015;104(1):58–66. Scholar
  61. 61.
    Arcelus J, Mitchell AJ, Wales J, Nielsen S. Mortality rates in patients with anorexia nervosa and other eating disorders: A meta-analysis of 36 studies. Archives of General Psychiatry. 2011;68(7):724–731. Scholar
  62. 62.
    Ejaz SM, Khawaja IS, Bhatia S, Hurwitz TD. Obstructive sleep apnea and depression: A review. Innovations in Clinical Neuroscience. 2011;8(8):17–25.PubMedPubMedCentralGoogle Scholar
  63. 63.
    Crump C, Winkleby MA, Sundquist K, Sundquist J. Comorbidities and mortality in persons with schizophrenia: A Swedish national cohort study. American Journal of Psychiatry. 2013;170(3):324–333. Scholar
  64. 64.
    Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time? Archives of General Psychiatry. 2007;64(10):1123–1131. Scholar
  65. 65.
    Zivin K, Yosef M, Miller EM, et al. Associations between depression and all-cause and cause-specific risk of death: A retrospective cohort study in the Veterans Health Administration. Journal of Psychosomatic Research. 2015;78(4):324–331. Scholar
  66. 66.
    Pederson JL, Warkentin LM, Majumdar SR, McAlister FA. Depressive symptoms are associated with higher rates of readmission or mortality after medical hospitalization: A systematic review and meta‐analysis. Journal of Hospital Medicine. 2016;11(5):373–380. Scholar
  67. 67.
    World Health Organization. International classification of functioning, disability and health: ICF. Geneva, Switzerland: World Health Organization; 2001.Google Scholar
  68. 68.
    Honan CA, Brown RF, Hine DW, et al. The multiple sclerosis work difficulties questionnaire. Multiple Sclerosis Journal. 2012;18(6):871–880. Scholar
  69. 69.
    Australian Human Rights Commission. Willing to work: National inquiry into employment discrimination against older Australians and Australians with disability; 2015. Accessed 3 November 2015.
  70. 70.
    Scott K, Von Korff M, Alonso J, et al. Mental–physical co-morbidity and its relationship with disability: Results from the World Mental Health Surveys. Psychological Medicine. 2009;39(1):33–43. Scholar
  71. 71.
    Schoevers RA, Deeg D, Van Tilburg W, Beekman A. Depression and generalized anxiety disorder: Co-occurrence and longitudinal patterns in elderly patients. The American Journal of Geriatric Psychiatry. 2005;13(1):31–39. Scholar
  72. 72.
    Kurawa SS. The impact of disability on self and society: An agenda for research on rehabilitation of disabled in Nigeria. Procedia-Social and Behavioral Sciences. 2010;5:1804–1810. Scholar
  73. 73.
    Hatzenbuehler ML, Phelan JC, Link BG. Stigma as a fundamental cause of population health inequalities. American Journal of Public Health. 2013;103(5):813–821. Scholar
  74. 74.
    Kamieniecki GW. Prevalence of psychological distress and psychiatric disorders among homeless youth in Australia: A comparative review. Australian and New Zealand Journal of Psychiatry. 2001;35(3):352–358.CrossRefGoogle Scholar
  75. 75.
    Williams A. Patients with comorbidities: Perceptions of acute care services. Journal of Advanced Nursing. 2004;46(1):13–22. Scholar
  76. 76.
    van der Aa MJ, van den Broeke JR, Stronks K, Plochg T. Patients with multimorbidity and their experiences with the healthcare process: A scoping review. Journal of Comorbidity. 2017;7(1):11–21.CrossRefGoogle Scholar
  77. 77.
    Marais BJ, Lönnroth K, Lawn SD, et al. Tuberculosis comorbidity with communicable and non-communicable diseases: Integrating health services and control efforts. The Lancet Infectious Diseases. 2013;13(5):436–448. Scholar
  78. 78.
    Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: Implications for pay for performance. JAMA. 2005;294(6):716–724. Scholar

Copyright information

© The Author(s) 2020

Authors and Affiliations

  1. 1.Australian National UniversityCanberraAustralia
  2. 2.University of New EnglandArmidaleAustralia

Personalised recommendations